Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies (NCT03680677)
Prospective Analysis of Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research study is to determine if frailty assessments can be used to predict how well patients aged 60 years and older will do after chemotherapy, CAR T-cell therapy, or allogeneic stem cell transplant.
Who can join: Review the eligibility criteria below.
Location: Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
Age range: 60 Years
🧪 Interventions in This Study
- Bone Marrow or Peripheral Blood Graft (BMT) (PROCEDURE)
- Cancer-directed Therapy or Best Supportive Care (OTHER)
- Frailty Assessment (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (855) 216-0098
Email: penncancertrials@emergingmed.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Leukemia, Acute
- Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS — Charlottesville, Virginia
- Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients — Baltimore, Maryland
- Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention — Boston, Massachusetts
Explore by condition: All Leukemia, Acute clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.